Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)

NCT01817569 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01817569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01817569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 13, 2011
Completion date
October 3, 2019
Enrollment
2,948 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes